Atlas Trials

Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma

Clinical trial NCT06527495 · UNKNOWN

Trial details

NCT number
NCT06527495
Sponsor
Assiut University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
HCCHepatocellular Carcinoma
Start date
2023-01-01
Primary completion
2024-12-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.